News | January 05, 2015

ProCure Proton Therapy Center in New Jersey Celebrates 1,000th Patient

Major milestone marks greater access to proton therapy both locally and abroad

January 5, 2015 — Zelina Amir was the 1,000th patient to complete treatment at the ProCure Proton Therapy Center in Somerset, New Jersey. Amir, who traveled to ProCure from Israel, was treated for a hemangioblastoma of the spine.

Proton therapy is a precise form of radiation that directly attacks tumors while minimizing potentially damaging radiation to surrounding healthy tissues and organs, and is beneficial for difficult-to-reach tumors and complex cases.

After getting in a car accident in 2006, a CT scan found a small tumor in Amir's spine, but it was recommended at that time that it not be treated by any means due to its sensitive location. In 2011, Amir was diagnosed with breast cancer, and it was then discovered that her hemangioblastoma tumor had grown larger and now mandated treatment. Since 2012, Amir has had five surgeries on her spine, only for the tumor to grow back. Amir’s doctors in Israel told her about proton therapy and ProCure, feeling strongly that it was the key to her recovery.

Studies have shown proton therapy to be effective in treating many types of cancers, including tumors of the brain, gastrointestinal system, head and neck region and prostate, as well as sarcomas and most pediatric cancers. The precision of proton therapy makes it especially effective for treating children and adults with anatomically complex tumors, such as tumors that are inoperable, located at the base of the skull, or along the spinal cord.

For more information:


Related Content

MedStar Georgetown Proton Center Selects RayStation for Treatment Planning
News | Treatment Planning | August 17, 2017
August 17, 2017 — The proton center at MedStar Georgetown University Hospital will utilize RayStation for planning on
DOSIsoft Releases ISOgray Proton Therapy Treatment Planning System
Technology | Treatment Planning | August 15, 2017
DOSIsoft SA announced the official release, with CE marking, of ISOgray Treatment Planning System (TPS) release 4.3 for...
Eight Proton Therapy Centers Worldwide Adopt RayStation for Treatment Planning
News | Treatment Planning | July 21, 2017
RaySearch Laboratories reported that eight additional proton therapy centers worldwide have recently chosen RayStation...
IBA to Install Proton Therapy Facility at Inova Schar Cancer Institute
News | Proton Therapy | July 18, 2017
IBA (Ion Beam Applications S.A.) and Inova recently signed a contract for a two-room Proteus Plus proton therapy...
Proton International and Beaumont Health Open Michigan's First Proton Therapy Facility
News | Proton Therapy | July 17, 2017
Proton International (PI) and Beaumont Health recently opened the state’s first proton therapy center, offering the...
ASTRO Updates Insurance Coverage Recommendations for Proton Therapy
News | Proton Therapy | July 17, 2017
The American Society for Radiation Oncology (ASTRO) has issued an update to its recommendations for medical insurance...
IBA and Philips Step Up Commercial Collaboration in Brazilian Proton Therapy Market
News | Radiation Therapy | July 03, 2017
IBA and Philips announced in mid-June they are stepping up their combined effort for proton therapy in Brazil.
First Patient Treated With Pencil Beam Scanning at Institute Curie Proton Therapy Center
News | Proton Therapy | May 23, 2017
May 23, 2017 — IBA announced that the first patient has been treated with pencil beam scanning (PBS) technology at th
News | Radiation Therapy | May 16, 2017
Proton International announced the successful financing of a new state-of-the-art radiation therapy center and a...
Proton Monte Carlo Dose Calculation Now Part of RayStation Treatment Planning
News | Treatment Planning | May 15, 2017
RaySearch demonstrated a new Monte Carlo dose planning feature for proton therapy on its RayStation system at the 2017...
Overlay Init